Howard Fine
Weill Medical College of Cornell University · Prism Vision Group · Fine, Hoffman, and Packer LLC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Howard Fine as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 17:28 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05183204 · Paxalisib With a High Fat, Low Carb Diet and Metformin for GlioblastomaWeill Medical College of Cornell University · completed · Glioblastoma · principal investigator
- Ph2NCT04691960 · A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic ImagingWeill Medical College of Cornell University · active not recruiting · Glioblastoma · principal investigator
- N/ANCT02126423 · Resistance to Antibiotics in Patients Receiving Eye InjectionsPrism Vision Group · completed · Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Retinopathy · principal investigator
- N/ANCT00762281 · Safety and Effectiveness Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of HyperopiaCarl Zeiss Meditec, Inc. · completed · Hyperopia · principal investigator
- N/ANCT00762541 · Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Moderate to High MyopiaCarl Zeiss Meditec, Inc. · completed · Myopia · principal investigator
- N/ANCT00761826 · Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Mixed AstigmatismCarl Zeiss Meditec, Inc. · completed · Mixed Astigmatism · principal investigator
- Ph2NCT00667394 · Tandutinib Plus Bevacizumab to Treat Recurrent Brain TumorsNational Cancer Institute (NCI) · completed · Glioblastoma, Gliosarcoma, Anaplastic Astrocytoma · principal investigator
- Ph2NCT00459381 · Pazopanib in Treating Patients With Recurrent GlioblastomaNational Cancer Institute (NCI) · completed · Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma · principal investigator
- Ph1/Ph2NCT00085540 · FR901228 in Treating Patients With Recurrent High-Grade GliomasNational Cancer Institute (NCI) · completed · Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 17:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 26 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Biosignature CoreP30MH144896 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · fiscal years 2026 · $193,068 awarded in 2026Same name and institution; not confirmed by an ID
- Identifying and Targeting 3D Regulatory Nodes that Maintain Glioblastoma ProgramsR01NS136475 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · fiscal years 2024 to 2026 · $675,615 awarded in 2026Same name and institution; not confirmed by an ID
- Human Brain Cancer, Rather than Brain Cancer Cells, on a PlateDP1CA228040 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · fiscal years 2017 to 2021 · $1,186,500 awarded in 2021Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- NABTC Central Operation Grant (UCSF Project Leader)U01CA062399 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MICHAEL D PRADOS · fiscal years 1994 to 2008Named on NCT00459381, NCT00085540
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 17:28 UTC. The ranking covers the 200 most relevant of 40 PubMed records, and a shared surname and initials can bring in a namesake. All 40 on PubMed
- Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma.J Clin Oncol · 20091,281 citationsRCR 31.5
- Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma.J Clin Oncol · 2010408 citationsRCR 10.1
- Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.J Clin Oncol · 2000363 citationsRCR 8.9
- Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.Clin Cancer Res · 2006319 citationsRCR 7.0
- A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy.Neuro Oncol · 2010220 citationsRCR 5.3
- A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.Int J Radiat Oncol Biol Phys · 2015175 citationsRCR 5.9
- 165 citationsRCR 3.8
- 165 citationsRCR 4.0
- A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.Neuro Oncol · 2006162 citationsRCR 3.9
- 149 citationsRCR 4.0